ZAMEROVIMAB

UNII:	DX0L1Z7JO9
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ZAMEROVIMAB
GSRS Full Record:	DX0L1Z7JO9 i

2419087-87-7
CTB-011
CTB011
Immunoglobulin G1, anti-(rabies lyssavirus spike glycoprotein G) (human-Mus musculus clone 1A9 γ1-chain), disulfide with human-Mus musculus clone 1A9 κ -chain, dimer
SYN-023 COMPONENT CTB-011
SYN023 COMPONENT CTB-011
ZAMEROVIMAB [USAN]
Zamerovimab
Zamerovimab [WHO-DD]
immunoglobulin G1-kappa, anti-[rabies lyssavirus (rabies virus, RABV) spike glycoprotein G], humanized monoclonal antibody; gamma1 heavy chain humanized (1-451) [VH (Homo sapiens IGHV1-3*01 (80.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo sapiens IGHG1*01 (100%), G1m17,1 (CH1 K120 (218) (122-219), hinge 1-15 (220-234), CH2 (235-344), CH3 D12 (360), L14 (362) (345-449), CHS (450-451)) (122-451)], (224-214')-disulfide with kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-16*01 (86.3%) -IGKJ2*02 (100%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; dimer (230-230'':233-233'')-bisdisulfide, produced in a Chinese hamster ovary (CHO)-DG44 cell line, glycoform alfa
zamerovimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZAMEROVIMAB

Synonyms and Mappings

Resources